Haemonetics Corp. (HAE)
Low worldwide penetration combined with demand outstripping supply makes a positive long-term thesis for investing in the blood processing and supply chain management industry. Haemonetics Corp. (HAE - Analyst Report) has benefited from recent acquisitions that have added novel technologies.
Additionally, recent supply agreements and double-digit growth demonstrate HAE's strong market position in a growing industry.
|
|
|
Share |
RSS |
Rate Pos |
Rate Neg |
Comment |
|
|
||||||
Loading Stories...Most Popular on Zacks.com
More Zacks Resources
More Zacks Links
| Market Summary | Nov 08, 2009 12:14 pm ET |


Sponsored Links 
-0.14 %
17.46
[CLICK TO CLOSE X]